You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

I-70

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Lymphoma Trial in Beijing (CD70-targeting CAR-T cells)

Recruiting
  • Lymphoma
  • CD70-targeting CAR-T cells
  • Beijing, Biotherapeutic Department Of Chinsese PLA Gereral Hospital, China
    China
Jul 9, 2023

Solid Tumor, Adult Trial in Beijing (CD70-targeting CAR-T cells)

Recruiting
  • Solid Tumor, Adult
  • CD70-targeting CAR-T cells
  • Beijing, Iotherapeutic Department Of Chinsese PLA Gereral Hospital, China
    China
Jul 8, 2023

Renal Cell Carcinoma, Ovarian Cancer, Cervix Cancer Trial in Nanchang (CD70 CAR-T cells)

Recruiting
  • Renal Cell Carcinoma
  • +4 more
  • CD70 CAR-T cells
  • Nanchang, Jiangxi, China
    The First Affiliated Hospital of Nanchang University
Aug 23, 2023

Hematologic Malignancies Trial in Los Angeles (Cyclophosphamide)

Not yet recruiting
  • Hematologic Malignancies
  • Los Angeles, California
    Cedars-Sinai Medical Center
May 5, 2023

Glioblastoma Trial in Gainesville (Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells)

Not yet recruiting
  • Glioblastoma
  • Ex-Vivo expanded autologous IL-8 receptor (CXCR2) modified CD70 CAR (8R-70CAR) T cells
  • Gainesville, Florida
    University of Florida Health
Jul 29, 2022

Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma Trial in Zhengzhou (CD70 CAR-T cells)

Recruiting
  • Metastatic Tumor
  • +4 more
  • CD70 CAR-T cells
  • Zhengzhou, Henan, China
    Henan Cancer Hospital
Jul 19, 2022

Metastatic Tumor, Advanced Solid Tumor, Renal Cell Carcinoma Trial in Jinan (CD70 CAR-T cells)

Recruiting
  • Metastatic Tumor
  • +4 more
  • CD70 CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jun 14, 2022

Metastatic Tumor, Renal Cell Carcinoma, Advanced Cancer Trial in Jinan (CD70 CAR-T cells)

Recruiting
  • Metastatic Tumor
  • +2 more
  • CD70 CAR-T cells
  • Jinan, Shandong, China
    The Second People's Hospital of Shandong Province
Jun 26, 2022

COVID-19 Trial (HLX70, Placebo)

Withdrawn
  • COVID-19
  • (no location specified)
Jun 20, 2022

Advanced Renal Cell Carcinoma, Advanced Mesothelioma, Advanced Osteosarcoma Trial in Houston (CAR.70/IL15-transduced CB-derived

Not yet recruiting
  • Advanced Renal Cell Carcinoma
  • +2 more
  • CAR.70/IL15-transduced CB-derived NK cells
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Jan 27, 2023

B-Cell Lymphoma, MDS (MDS), Acute Myeloid Leukemia (AML) Trial in Houston (Cyclophosphamide, CAR.70/IL15-transduced CB-NK cells,

Not yet recruiting
  • B-Cell Lymphoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
May 12, 2022

COVID 19 Trial (HLX70, Placebo)

Withdrawn
  • COVID 19
  • (no location specified)
Mar 20, 2022

ivness and Safety in Elderly Type 2 Diabetes Patients

Not yet recruiting
  • Type2Diabetes
  • SGLT2 inhibitor
  • Milan, Italy
    ASST FBF Sacco
Jul 25, 2022

Herpes Zoster, Vaccine-Preventable Diseases Trial (Low Dose Recombinant Herpes Zoster Vaccine (LZ901), High Dose Recombinant

Not yet recruiting
  • Herpes Zoster
  • Vaccine-Preventable Diseases
  • Low Dose Recombinant Herpes Zoster Vaccine (LZ901)
  • +2 more
  • (no location specified)
Feb 28, 2023

HIV Infection Primary Trial in Badalona (Dasatinib 70 mg, Placebo)

Not yet recruiting
  • HIV Infection Primary
  • Dasatinib 70 mg
  • Placebo
  • Badalona, Barcelona, Spain
    Hospital Universitari Germans Trias i Pujol
Mar 9, 2023

Clostridium Infections Trial in Gent (C. difficile investigational vaccine based on the F2 antigen (GSK2904545A), C. difficile

Completed
  • Clostridium Infections
  • C. difficile investigational vaccine based on the F2 antigen (GSK2904545A)
  • +2 more
  • Gent, Belgium
    GSK Investigational Site
Jun 9, 2022

Glioblastoma Trial in Louisville (Hypofractionated radiotherapy, Temozolomide)

Recruiting
  • Glioblastoma
  • Louisville, Kentucky
    James Graham Brown Cancer Center
Oct 22, 2021

Graves' Disease Trial in Liverpool, Manchester (K1-70 intramuscular or K1-70 intravenous)

Completed
  • Graves' Disease
  • K1-70 intramuscular or K1-70 intravenous
  • Liverpool, United Kingdom
  • +1 more
May 18, 2021

Ovarian Tumors, BRCA1 Protein, BRCA2 Protein Trial in Worldwide (KU-0059436 (AZD2281)(PARP inhibitor))

Active, not recruiting
  • Ovarian Neoplasms
  • +2 more
  • KU-0059436 (AZD2281)(PARP inhibitor)
  • Brussels, Belgium
  • +4 more
Dec 19, 2022

Advanced / Metastatic Solid Tumors Trial (MAX-40279-01: 50mg/70mg)

Not yet recruiting
  • Advanced / Metastatic Solid Tumors
  • MAX-40279-01: 50mg/70mg
  • (no location specified)
Jun 16, 2022

Healthy Lifestyle Trial in Worldwide (Intervention Group)

Completed
  • Healthy Lifestyle
  • Intervention Group
  • Athens, Kallithea, Greece
  • +3 more
Dec 15, 2022

Breast Cancer Trial in Nice (IPAS)

Completed
Has Results
  • Breast Cancer
  • IPAS
  • Nice, France
    Centre Antoine Lacassagne
Nov 3, 2021

NSCLC Stage IV, KRAS P.G12C Trial in Worldwide (Adagrasib)

Not yet recruiting
  • NSCLC Stage IV
  • KRAS P.G12C
  • Brussels, Belgium
  • +26 more
Jan 3, 2023

Carcinoma, Non-Small-Cell Lung Trial in Worldwide (Lorlatinib)

Recruiting
  • Carcinoma
  • Non-Small-Cell Lung
  • Orange, California
  • +31 more
Dec 6, 2022

Lanadelumab in Persons With Hereditary Angioedema in Poland

Recruiting
  • Hereditary Angioedema (HAE)
    • Wrocław, Dolnośląskie, Poland
    • +13 more
    Jun 15, 2022